Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Active not recruiting 5Recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2Gastrointestinal 1

Conditions

Advanced Biliary Tract Cancer(BTC) 1

Interventions

Oxaliplatin 86Bevacizumab 66Capecitabine 65Fluorouracil 48tislelizumab 41Gemcitabine 40Drug Therapy 39Leucovorin 38sintilimab 35Irinotecan 34lenvatinib 27Cisplatin 27HMPL-013 25S 1 (combination) 23camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20130-nm albumin-bound paclitaxel 20toripalimab 19Paclitaxel 18Folfox protocol 17pembrolizumab 15Immunotherapy 15Cetuximab 15Specimen Handling 14regorafenib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × relatlimab × Gastrointestinal × Clear all
NCT07369791 2026-01-28

NOBLE

National Health Research Institutes, Taiwan

Phase 2 Not yet recruiting
76 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer(BTC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡